Fig. 4From: Identification of characteristic metabolic panels for different stages of prostate cancer by 1H NMR-based metabolomics analysisROC curve analysis of the selected metabolites for discriminating PCaB from PCa. The assessment of the diagnostic performance of A LDL/VLDL; B isoleucine; C valine; D 3-HB; E alanine; F pyruvate; G citrate; H creatine; I a combination of eight metabolites; J a merger of eight metabolites with age and BMIBack to article page